SCHEMBL20175682

SCHEMBL20175682

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4cc(-c5cc6c7ccccc7n(-c7ccccc7)c6c6c5oc5ccccc56)ccc43)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.33
▸ TSHR P16473 4/20 0.33
▸ PTGER4 P35408 1/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ ATM Q13315 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ SIRT2 Q8IXJ6 1/20 0.32
▸ SIRT1 Q96EB6 1/20 0.32
▸ LMNA P02545 5/20 0.32
▸ HSD17B10 Q99714 3/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ ALDH1A1 P00352 5/20 0.31
▸ POLB P06746 3/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KMT2A Q03164 3/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ BRCA1 P38398 1/20 0.31
▸ PTGER1 P34995 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18561399 0.90 MAPT (0.37) MAPTTSHRKDM4EATML3MBTL1
SCHEMBL20175676 0.89 KDM4E (0.43) TSHRPTGER4KDM4EATML3MBTL1
SCHEMBL24276442 0.88 MAPT (0.34) MAPTTSHRKDM4EATML3MBTL1
SCHEMBL20175679 0.88 KDM4E (0.40) TSHRKDM4EATML3MBTL1LMNA
SCHEMBL27324269 0.88 MAPT (0.37) MAPTTSHRKDM4ELMNAHSD17B10
SCHEMBL18868049 0.88 MAPT (0.38) MAPTTSHRKDM4ELMNAHSD17B10
SCHEMBL19862979 0.87 KDM4E (0.34) MAPTTSHRPTGER4KDM4EATM
SCHEMBL17252413 0.86 MAPT (0.33) MAPTTSHRPTGER4KDM4EATM
SCHEMBL17252407 0.86 KDM4E (0.38) MAPTTSHRPTGER4KDM4EATM
SCHEMBL19862981 0.86 KDM4E (0.33) MAPTTSHRPTGER4KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717744-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-07-21 — — US disclosed
US-20180141957-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-24 — — US disclosed
US-20180141957-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141957-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 MAPT 3092/4885TSHR 4692/4885PTGER4 1503/4885
US-10717744-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, LEF1 MAPT 3092/4885TSHR 4692/4885PTGER4 1503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback